Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I-Mei Yu

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Blood Advances|July 15, 2022
Differences in wild-type- and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepanciesJonathan H Foley, Erald Shehu, Anne Riddell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2025
FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1Fabrizio Comper, Carlos J Miranda, Benjamin Liou, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Blood Advances|July 15, 2022
Differences in wild-type- and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepanciesJonathan H Foley, Erald Shehu, Anne Riddell, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 9, 2025
FLT201, a novel liver-directed AAV gene therapy candidate for Gaucher disease type 1Fabrizio Comper, Carlos J Miranda, Benjamin Liou, et al.
Pageof 2